GPR40 agonist 4

2102196-57-4

C21H17ClO5S

DMSO : 160 mg/mL (383.81 mM; Need ultrasonic and warming)

GPCR/G Protein

GPR40 agonist 4 is a potent free fatty acid receptor 1 (FFA1/ GPR40) agonist with a pEC₅₀ of 7.54. IC50 & Target: pEC₅₀: 7.54 (FFA1/GPR40)^[1] In Vitro: GPR40 agonist 4 tends to have a low risk of activating caspase-3/7^[1]. In Vivo: Single oral administration of GPR40 agonist 4 (compound 20) robustly reduces the plasma glucose excursion and enhances insulin secretion during an oral glucose tolerance test (OGTT) in a dose-dependent manner from 1 to 10 mg/kg when GPR40 agonist 4 is dosed 60 min prior to the oral glucose challenge. The area under the curve of blood glucose (AUC_0-120min) and blood insulin (AUC_0-120min) reveal that the minimum effective dose of GPR40 agonist 4 is 3 mg/kg. The hyperglycemia state is also markedly improved in GPR40 agonist 4 (20 mg/kg) treated group^[1].